Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events

Nathan D. Wong; Heidi Gransar; Jagat Narula; Leslee J. Shaw; Johanna H. Moon; Romalisa Miranda-Peats; Alan Rozanski; Sean W. Hayes; Louise E.J. Thomson; John D. Friedman; Daniel S. Berman

doi:https://doi.org/10.1016/j.jcmg.2009.05.012

doi.org/10.1016/j.jcmg.2009.05.012

Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events

,

,

..., Daniel S. Berman

130

JACC: Cardiovascular Imaging14.00

Volume: 2, Issue: 9, Pages: 1093 - 1099

Published: Sep 1, 2009

Abstract

We evaluated whether myeloperoxidase (MPO) predicts future cardiovascular disease (CVD) events in asymptomatic adults and whether subclinical atherosclerosis may affect this relation.Myeloperoxidase is a leukocyte-derived enzyme-generating reactive oxidant species that has been shown to predict risk of CVD in selected populations.We studied 1,302 asymptomatic adults (mean age 59 years, 47% women) without known CVD who were followed for 3.8...

Paper Fields

Paper Details

Title

Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events

DOI

doi.org/10.1016/j.jcmg.2009.05.012

Published Date

Sep 1, 2009

Journal

JACC: Cardiovascular Imaging

Volume

2

Issue

9

Pages

1093 - 1099

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History